Thinking versus feeling: How interoception and cognition influence emotion recognition in behavioural-variant frontotemporal dementia, Alzheimer's disease, and Parkinson's disease.


Journal

Cortex; a journal devoted to the study of the nervous system and behavior
ISSN: 1973-8102
Titre abrégé: Cortex
Pays: Italy
ID NLM: 0100725

Informations de publication

Date de publication:
06 2023
Historique:
received: 18 07 2022
revised: 18 11 2022
accepted: 17 02 2023
medline: 17 5 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Disease-specific mechanisms underlying emotion recognition difficulties in behavioural-variant frontotemporal dementia (bvFTD), Alzheimer's disease (AD), and Parkinson's disease (PD) are unknown. Interoceptive accuracy, accurately detecting internal cues (e.g., one's heart beating), and cognitive abilities are candidate mechanisms underlying emotion recognition. One hundred and sixty-eight participants (52 bvFTD; 41 AD; 24 PD; 51 controls) were recruited. Emotion recognition was measured via the Facial Affect Selection Task or the Mini-Social and Emotional Assessment Emotion Recognition Task. Interoception was assessed with a heartbeat detection task. Participants pressed a button each time they: 1) felt their heartbeat (Interoception); or 2) heard a recorded heartbeat (Exteroception-control). Cognition was measured via the Addenbrooke's Cognitive Examination-III or the Montreal Cognitive Assessment. Voxel-based morphometry analyses identified neural correlates associated with emotion recognition and interoceptive accuracy. All patient groups showed worse emotion recognition and cognition than controls (all P's ≤ .008). Only the bvFTD showed worse interoceptive accuracy than controls (P < .001). Regression analyses revealed that in bvFTD worse interoceptive accuracy predicted worse emotion recognition (P = .008). Whereas worse cognition predicted worse emotion recognition overall (P < .001). Neuroimaging analyses revealed that the insula, orbitofrontal cortex, and amygdala were involved in emotion recognition and interoceptive accuracy in bvFTD. Here, we provide evidence for disease-specific mechanisms for emotion recognition difficulties. In bvFTD, emotion recognition impairment is driven by inaccurate perception of the internal milieu. Whereas, in AD and PD, cognitive impairment likely underlies emotion recognition deficits. The current study furthers our theoretical understanding of emotion and highlights the need for targeted interventions.

Identifiants

pubmed: 37075507
pii: S0010-9452(23)00060-6
doi: 10.1016/j.cortex.2023.02.009
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

66-79

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors report no competing interests.

Auteurs

Jessica L Hazelton (JL)

The University of Sydney, School of Psychology, Sydney, Australia; The University of Sydney, Brain & Mind Centre, Sydney, Australia.

Sol Fittipaldi (S)

Cognitive Neuroscience Center (CNC) Universidad de San Andres, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Facultad de Psicología, Universidad Nacional de Córdoba, Argentina; Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile.

Matias Fraile-Vazquez (M)

Cognitive Neuroscience Center (CNC) Universidad de San Andres, Buenos Aires, Argentina.

Marion Sourty (M)

The University of Sydney, Brain & Mind Centre, Sydney, Australia; The University of Sydney, School of Engineering, Sydney, Australia.

Agustina Legaz (A)

Cognitive Neuroscience Center (CNC) Universidad de San Andres, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Facultad de Psicología, Universidad Nacional de Córdoba, Argentina.

Anna L Hudson (AL)

Flinders University, College of Medicine and Public Health, Adelaide, Australia; Neuroscience Research Australia (NeuRA), Sydney, Australia; The University of New South Wales, School of Medical Sciences, Sydney, Australia.

Indira Garcia Cordero (IG)

Cognitive Neuroscience Center (CNC) Universidad de San Andres, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada.

Paula C Salamone (PC)

National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Department of Biomedical and Clinical Sciences, Center for Social and Affective Neuroscience, Linköping University, Linköping, Sweden.

Adrian Yoris (A)

National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Institute of Cognitive and Translational Neuroscience (INCYT), Buenos Aires, Argentina.

Agustín Ibañez (A)

Cognitive Neuroscience Center (CNC) Universidad de San Andres, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile; Global Brain Health Institute, University of California, San Francisco, USA; Trinity College Dublin (TCD), Dublin, Ireland.

Olivier Piguet (O)

The University of Sydney, School of Psychology, Sydney, Australia; The University of Sydney, Brain & Mind Centre, Sydney, Australia.

Fiona Kumfor (F)

The University of Sydney, School of Psychology, Sydney, Australia; The University of Sydney, Brain & Mind Centre, Sydney, Australia. Electronic address: fiona.kumfor@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH